A prospective, open, observational cohort study of BNT162b2 mRNA (Pfizer–BioNTech) and ChAdOx1 nCoV-19 (Oxford–AstraZeneca) vaccines in Scotland
Latest Information Update: 04 May 2021
At a glance
- Drugs AZD 1222 (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 04 May 2021 Interim Results published in the Lancet
- 04 May 2021 New trial record